Literature DB >> 16830699

Iron indices: what do they really mean?

D Coyne1.   

Abstract

Routine monitoring of body iron stores is an essential component of overall management for the patient on hemodialysis. Adequate iron levels are important for the prevention and treatment of iron-deficiency anemia, which is associated with reduced physical functioning, cardiovascular disease, and poor quality of life. Hemodialysis patients are at especially high risk for iron-deficiency anemia, owing to continuous blood losses and supraphysiologic levels of erythropoiesis driven by recombinant human erythropoietin therapy. Unfortunately, the accurate determination of iron status in these patients can be a challenging task, which is made more difficult by inflammation, infections, and the large number of comorbid conditions that can affect commonly used indices of body iron stores. Despite their limitations, transferrin saturation (TSAT) and serum ferritin remain the cornerstones of iron status assessment. Because these values can be altered by a number of non-iron-related factors, it is necessary to go beyond these measures and draw upon additional sources of information to determine the patient's iron status. Other important factors to consider when assessing the need for iron therapy include evidence of underlying inflammatory processes that may block iron mobilization and distort the standard iron indices, the results of alternative iron indices, and the patient's recent history of iron administration. Frequently, the response to a gram of intravenous (i.v.) iron is a safe and effective way to determine the role of iron deficiency in the anemia of the problematic patient. The chronic inflammatory state associated with malnutrition and clinical or subclinical infections substantially increases the risk of misdiagnosing the patient with iron overload and may place the patient at risk of iron deficiency owing to inappropriate withdrawal of i.v. iron therapy. To avoid the risks of withholding iron therapy, the nephrologist must keep this relationship in mind whenever serum ferritin testing suggests replete iron stores, whereas TSAT testing suggests insufficient iron availability.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16830699     DOI: 10.1038/sj.ki.5000404

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  15 in total

Review 1.  Ferritin for the clinician.

Authors:  Mary Ann Knovich; Jonathan A Storey; Lan G Coffman; Suzy V Torti; Frank M Torti
Journal:  Blood Rev       Date:  2008-10-02       Impact factor: 8.250

2.  Low hemoglobin density as a measure of iron status.

Authors:  Sharat Damodar; Sneha T Raghunath; Sreedhar Murthy; K J Jayanthi; B R S Latha
Journal:  Indian J Hematol Blood Transfus       Date:  2012-05-26       Impact factor: 0.900

3.  Appropriateness of anemia management in hemodialysis patients.

Authors:  Nahla A Al-Ageel; Sinaa A Al-Aqeel; Norah O Abanmy; Jamal S Alwakeel; Alaa Sabry; Khalid A Alsaran
Journal:  Saudi Pharm J       Date:  2011-09-16       Impact factor: 4.330

4.  Serum ferritin level remains a reliable marker of bone marrow iron stores evaluated by histomorphometry in hemodialysis patients.

Authors:  Lillian A Rocha; Daniela V Barreto; Fellype C Barreto; Cristiane B Dias; Rosa Moysés; Maria Regina R Silva; Luiz A R Moura; Sérgio A Draibe; Vanda Jorgetti; Aluízio B Carvalho; Maria Eugênia F Canziani
Journal:  Clin J Am Soc Nephrol       Date:  2008-10-08       Impact factor: 8.237

Review 5.  Diagnosis of anaemia: old things rearranged.

Authors:  Gabriele Halwachs-Baumann
Journal:  Wien Med Wochenschr       Date:  2012-11-08

6.  Erythrocyte and Reticulocyte Indices on the LH 750 as Potential Markers of Functional Iron Deficiency.

Authors:  Eloísa Urrechaga; Luís Borque; Jesús F Escanero
Journal:  Anemia       Date:  2010-06-16

7.  Iron Deficiency Anemia in Adult Onset Still's Disease with a Serum Ferritin of 26,387 μg/L.

Authors:  Sheetal Patel; Seyed Monemian; Ayesha Khalid; Harvey Dosik
Journal:  Anemia       Date:  2011-05-12

8.  Diagnostic utility of low hemoglobin density to detect iron deficiency in patients with inflammatory bowel disease.

Authors:  Karima Farrag; Krenare Ademaj; Eleni Leventi; Aysegül Aksan; Jürgen Stein
Journal:  Ann Gastroenterol       Date:  2021-04-02

Review 9.  Biomarkers of hypochromia: the contemporary assessment of iron status and erythropoiesis.

Authors:  Eloísa Urrechaga; Luís Borque; Jesús F Escanero
Journal:  Biomed Res Int       Date:  2013-02-28       Impact factor: 3.411

10.  Adequacy of maternal iron status protects against behavioral, neuroanatomical, and growth deficits in fetal alcohol spectrum disorders.

Authors:  Echoleah S Rufer; Tuan D Tran; Megan M Attridge; Matthew E Andrzejewski; George R Flentke; Susan M Smith
Journal:  PLoS One       Date:  2012-10-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.